Accessibility Menu
 

VivoSim Labs

(NASDAQ) VIVS

Current Price$1.54
Market Cap$3.99M
Since IPO (2012)-100%
5 Year-99%
1 Year-28%
1 Month-19%

VivoSim Labs Financials at a Glance

Market Cap

$3.99M

Revenue (TTM)

$142.00K

Net Income (TTM)

$1.23M

EPS (TTM)

$0.47

P/E Ratio

3.29

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Price

$1.54

Volume

1

Open

$1.58

Previous Close

$1.53

Daily Range

$1.52 - $1.58

52-Week Range

$1.25 - $5.30

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About VivoSim Labs

Industry

Biotechnology

Employees

13

CEO

Keith Murphy

Website

vivosim.ai

Headquarters

San Diego, CA 92121, US

VIVS Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-81%

Net Income Margin

-9%

Return on Equity

-51%

Return on Capital

-3%

Return on Assets

-18%

Earnings Yield

30.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.99M

Shares Outstanding

2.61M

Volume

1

Short Interest

0.00%

Avg. Volume

1.67M

Financials (TTM)

Gross Profit

$139.00K

Operating Income

$12.62M

EBITDA

$2.21M

Operating Cash Flow

$9.46M

Capital Expenditure

$13.00K

Free Cash Flow

$9.47M

Cash & ST Invst.

$11.31M

Total Debt

$942.00K

VivoSim Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$26.00K

+8.3%

Gross Profit

$26.00K

+18.2%

Gross Margin

100.00%

N/A

Market Cap

$3.99M

N/A

Market Cap/Employee

$285.01K

N/A

Employees

14

N/A

Net Income

$2.69M

+21.9%

EBITDA

$2.63M

+21.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$3.71M

+3574.3%

Accounts Receivable

$1.04M

+3915.4%

Inventory

$0.00

N/A

Long Term Debt

$44.00K

-91.9%

Short Term Debt

$533.00K

+3.1%

Return on Assets

-17.63%

N/A

Return on Invested Capital

-2.55%

N/A

Free Cash Flow

$2.27M

-26.1%

Operating Cash Flow

$2.27M

-26.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PMCBPharmaCyte Biotech, Inc.
$0.67-1.37%
QNRXQuoin Pharmaceuticals, Ltd.
$5.74-4.17%
KTTAPasithea Therapeutics Corp.
$0.72-6.01%
RADXRadiopharm Theranostics Limited
$4.67+4.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$67.86-0.02%
NOKNokia
$9.55+0.01%

Questions About VIVS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.